• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN. 3; GLYCOSYLATED HEMOGLOBIN ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN. 3; GLYCOSYLATED HEMOGLOBIN ASSAY Back to Search Results
Catalog Number 07559674190
Device Problems High Test Results (2457); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/23/2023
Event Type  malfunction  
Manufacturer Narrative
The c513 analyzer serial number is (b)(6).The field service representative (fsr) checked calibration, qc, and operator maintenance and did not identify any issues.Instrument performance testing was acceptable.Frequent abnormal aspiration alarms were observed on the alarm trace data.The investigation is ongoing.
 
Event Description
The initial reporter complained of discrepant high results for 2 patient samples tested for tina-quant hemoglobin a1cdx gen.3 on a cobas c513 analyzer.Patient 1 initial result was 7.41% on (b)(6) 2023 the sample was repeated on a cobas 8000 c 502 module with a result of 5.86%.Patient 2 initial result was 11.03%.On (b)(6) 2023 the sample was repeated on a cobas 8000 c 502 module with a result of 9.51%.
 
Manufacturer Narrative
The field service engineer (fse) made reagent and sample probe adjustments.The cuvette segments were seated properly.The sample probe was checked for obstructions by flushing.The fse noted that the reagent packs may have frozen in the customer's refrigerator.The customer has not complained of any further issues.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HEMOGLOBIN A1CDX GEN. 3
Type of Device
GLYCOSYLATED HEMOGLOBIN ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17766033
MDR Text Key323644038
Report Number1823260-2023-03008
Device Sequence Number1
Product Code LCP
UDI-Device Identifier04015630942787
UDI-Public04015630942787
Combination Product (y/n)Y
Reporter Country CodeEG
PMA/PMN Number
K072714
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2024
Device Catalogue Number07559674190
Device Lot Number67251001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-